Lya LifeSciences

This website is designed for visitors who want to understand Lya LifeSciences as a modern biopharma organization across science, products, trials, and stakeholder programs. It presents trusted corporate, scientific, and portal-oriented content in a clear structure so each audience can quickly find what matters to them. Every section uses synthetic but realistic data to demonstrate how a life sciences company site can support patients, HCPs, investigators, partners, investors, and candidates. Use the navigation and featured panels below to explore key programs, evidence updates, and governed workflow entry points.

Type: CorporateLast reviewed: 2026-02-28Owner: LegalStatus: Approved
Portfolio update: 24 active assets across 8 therapeutic areasClinical trials: 160 studies with deterministic search and site viewsInvestor events: webcast archive and KPI simulation now availablePatient support: financial assistance and education center expandedHCP portal: medical information request workflow with SLA routing

8

Commercial products

24

Pipeline assets

5

Phase 3 programs

4

Filed programs

32

Recruiting studies

Therapeutic Focus Areas

OncologyImmunologyNeurologyRare DiseaseCardiometabolicInfectious DiseaseHematologyRespiratory

Pipeline Momentum

Priority programs across oncology, immunology, neurology, rare disease, and cardiometabolic indications.

  • LYA-200 | Preclinical | Tier 1
  • LYA-201 | Phase 1 | Tier 2
  • LYA-202 | Phase 2 | Tier 3
  • LYA-203 | Phase 3 | Tier 1
View Pipeline Portfolio

Clinical Trial Discovery

Deterministic trial search with condition, phase, status, age group, and site filters for transparent discovery.

  • TRL-0001 | Oncology | Recruiting
  • TRL-0002 | Immunology | Active, not recruiting
  • TRL-0003 | Neurology | Completed
  • TRL-0004 | Rare Disease | Terminated
Search Clinical Trials

Integrated Biopharma Platform

From Discovery Through Delivery

Connected digital operating model spanning research strategy, clinical execution, medical affairs, safety, and global stakeholder communications.

DiscoveryClinicalLaunchLifecycle

Featured Program Signals

  • LYA-200 Orion-1 | Preclinical | NA
  • LYA-201 Helix-2 | Phase 1 | EU
  • LYA-202 Helix-3 | Phase 2 | APAC
Explore Scientific Platforms

Patients

Education, support and access workflows.

HCP

Product center, dosing and medical info.

Investigators

Trial operations and site metrics.

Partners

Alliance governance and data room.

Investors

Financials, events and disclosures.

Careers

Teams, roles and hiring process.